Brief communication: Enhancement of the antitumor effect of 1,-3-bis(2-chloroethyl)-1-nitrosourea by chlorpromazine and caffeine.
D000818:Animals; D002110:Caffeine / Q000008:administration & dosage / Q000627:therapeutic use*; D002330:Carmustine / Q000627:therapeutic use*; D002746:Chlorpromazine / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D007939:Leukemia L1210 / Q000188:drug therapy*; D008297:Male; D051379:Mice
D002110:Caffeine; D002746:Chlorpromazine; D002330:Carmustine